Integrating psychotherapy and pharmacotherapy.
In recent years, the dichotomy between psychotherapy and pharmacotherapy vis-à-vis the treatment of mood disorders has begun to be resolved as the benefits of integrating the two modalities are increasingly recognized. This new understanding has expanded the scope of successful treatment, but it has also complicated the process of making decisions about appropriate treatment. The author reviews the literature, illustrates some of the complex issues with case examples, and suggest guidelines for the mental health clinicians who must make such treatment decisions.
Adult Outpatient Department, C.F. Menninger Memorial Hospital, Topeka, KS.
J M
JM
Hyland
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy / Q000628:therapy; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000188:drug therapy / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019964:Mood Disorders / Q000188:drug therapy / Q000628:therapy*; D010554:Personality Disorders / Q000188:drug therapy / Q000628:therapy; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000627:therapeutic use*
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D011619:Psychotropic Drugs